The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current pharmaceutical design

• Publication date

  2009-03-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138161209787846711PMID 19355975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stromal gene expression predicts clinical outcome in breast cancer

  2008cited by this paper
• Targeting a tumor-specific laminin domain critical for human carcinogenesis.

  2008cited by this paper
• Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

  2008cited by this paper
• Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence.

  2008cited by this paper
• Evidence of galectin-1 involvement in glioma chemoresistance.

  2008cited by this paper
• Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors

  2008cited by this paper
• Extracellular matrix dynamics in development and regenerative medicine

  2008cited by this paper
• Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

  2008cited by this paper
• Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis?

  2008cited by this paper
• Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers

  2008cited by this paper
• Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion.

  2008cited by this paper
• Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells

  2008cited by this paper
• Galectin‐1 expression in cancer‐associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer

  2007cited by this paper
• Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.

  2007cited by this paper
• Heparanase: a target for drug discovery in cancer and inflammation

  2007cited by this paper
• Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.

  2007cited by this paper
• Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling.

  2007cited by this paper
• Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment.

  2007cited by this paper
• Clinical significance of MMP‐2 and MMP‐9 in patients with oral cancer

  2007cited by this paper
• Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor*

  2007cited by this paper
• Anti-cancer therapies targeting the tumor stroma

  2007cited by this paper
• Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.

  2007cited by this paper
• Telomere and telomerase in stem cells

  2007cited by this paper
• The Extracellular Matrix Protein TGFBI Induces Microtubule Stabilization and Sensitizes Ovarian Cancers to Paclitaxel

  2007cited by this paper
• Increased beta1 integrin is associated with decreased survival in invasive breast cancer.

  2007cited by this paper
• Laminin 332 in squamous-cell carcinoma

  2007cited by this paper
• Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma

  2007cited by this paper
• Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect

  2007cited by this paper
• Regulation of breast cancer response to chemotherapy by fibulin-1.

  2007cited by this paper
• Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.

  2007cited by this paper
• A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

  2007cited by this paper
• Tissue Geometry Determines Sites of Mammary Branching Morphogenesis in Organotypic Cultures

  2006cited by this paper
• Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

  2006cited by this paper
• Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression.

  2006cited by this paper
• Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation

  2006cited by this paper
• Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours.

  2006cited by this paper
• Novel heparanase-inhibiting antibody reduces neointima formation.

  2006cited by this paper
• Tumor-Targeting Properties of Novel Antibodies Specific to the Large Isoform of Tenascin-C

  2006cited by this paper
• Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo.

  2006cited by this paper
• Lysyl oxidase mediates hypoxic control of metastasis.

  2006cited by this paper
• Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

  2006cited by this paper
• Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

  2006cited by this paper
• The Impact of Heparanese and Heparin on Cancer Metastasis and Angiogenesis

  2006cited by this paper
• Focal Adhesion Kinase and Protein Kinase B Cooperate to Suppress Doxorubicin-Induced Apoptosis of Breast Tumor Cells

  2006cited by this paper
• N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.

  2006cited by this paper
• ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase

  2006cited by this paper
• Three new serum markers for prostate cancer detection within a percent free PSA‐based artificial neural network

  2006cited by this paper
• Fibronectin as target for tumor therapy

  2006cited by this paper
• Anti-galectin compounds as potential anti-cancer drugs.

  2006cited by this paper
• 1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.

  2006cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases.

  2005cited by this paper
• Tensional homeostasis and the malignant phenotype.

  2005cited by this paper
• Galectin-1 as a potential cancer target

  2005cited by this paper
• Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

  2005cited by this paper
• Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels

  2005cited by this paper
• Fibulins and cancer: friend or foe?

  2005cited by this paper
• Death in the third dimension: apoptosis regulation and tissue architecture.

  2004cited by this paper
• Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

  2004cited by this paper
• Small cell lung cancer: the importance of the extracellular matrix.

  2004cited by this paper
• Eosinophil major basic protein: first identified natural heparanase-inhibiting protein.

  2004cited by this paper
• Radiation-induced Histopathologic Changes of the Breast: The Effects of Time

  2004cited by this paper
• Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-β or wounding

  2004cited by this paper
• Role of tissue stroma in cancer cell invasion

  2003cited by this paper
• Tenascins: regulation and putative functions during pathological stress

  2003cited by this paper
• Investigating hypoxic tumor physiology through gene expression patterns

  2003cited by this paper
• Elevated expression and altered processing of fibulin-1 protein in human breast cancer

  2003cited by this paper
• The effects of inducible overexpression of FAK-related non-kinase (FRNK) on a transformed epithelial cell line.

  2003cited by this paper
• Inhibition of focal adhesion kinase by antisense oligonucleotides enhances the sensitivity of breast cancer cells to camptothecins.

  2003cited by this paper
• RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.

  2003cited by this paper
• Mesothelin-family proteins and diagnosis of mesothelioma.

  2003cited by this paper
• p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loop

  2003cited by this paper
• Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells

  2003cited by this paper
• Molecular design of bioconjugated cell adhesion peptide with a water-soluble polymeric modifier for enhancement of antimetastatic effect.

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Galectins and cancer.

  2002cited by this paper
• Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.

  2002cited by this paper
• Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.

  2002cited by this paper
• Suppression of Chemically Induced Apoptosis but Not Necrosis of Renal Proximal Tubular Epithelial (LLC-PK1) Cells by Focal Adhesion Kinase (FAK)

  2001cited by this paper
• Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.

  2001cited by this paper
• Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells

  2001cited by this paper
• DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.

  2001cited by this paper
• FAK integrates growth-factor and integrin signals to promote cell migration

  2000cited by this paper
• Heparanase expression in invasive trophoblasts and acute vascular damage.

  2000cited by this paper
• Tumor associated glycoprotein (TAG) 12: a new tumor marker in breast cancer.

  2000cited by this paper
• Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)

  2000cited by this paper
• Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis

  1999cited by this paper
• Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo

  1999cited by this paper
• Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin

  1999cited by this paper
• Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients

  1999cited by this paper
• Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

  1999cited by this paper
• Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

  1999cited by this paper
• Serum YKL-40 and colorectal cancer

  1999cited by this paper
• Clinical performance of the AMDL DR-70 immunoassay kit for cancer detection.

  1998cited by this paper
• CA 125: The past and the Future

  1998cited by this paper
• Human platelet heparanase: purification, characterization and catalytic activity.

  1998cited by this paper
• The discoidin domain receptor tyrosine kinases are activated by collagen.

  1997cited by this paper
• Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro‐cathepsin D immunoassay

  1997cited by this paper
• Heparanase and a Synthetic Peptide of Heparan Sulfate-interacting Protein Recognize Common Sites on Cell Surface and Extracellular Matrix Heparan Sulfate*

  1997cited by this paper
• Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

  1996cited by this paper

• Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies

  2025cites this paper
• Shielding and nurturing: Fibronectin as a modulator of cancer drug resistance

  2023cites this paper
• Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights

  2023cites this paper
• Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer

  2023cites this paper
• POTENTIAL OF MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN COLORECTAL CARCINOMA PATIENTS

  2022cites this paper
• Invasion and Secondary Site Colonization as a Function of In Vitro Primary Tumor Matrix Stiffness: Breast to Bone Metastasis

  2022cites this paper
• Vitronectin-based hydrogels recapitulate neuroblastoma growth conditions

  2022cites this paper
• Invasion and secondary site colonization as a function of in vitro primary tumor matrix stiffness

  2022cites this paper
• PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer

  2021cites this paper
• A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior

  2020cites this paper
• The impact of signaling factors on intervertebral disc degeneration and regeneration - studies on disc and mesenchymal stem cells from chronic low back pain patients

  2020cites this paper
• Matrix stiffness modulates ILK-mediated YAP activation to control the drug resistance of breast cancer cells.

  2019cites this paper
• [An integral view of cancer (I). The study, classification and reprogramming of the tumoral microclimate].

  2019cites this paper
• Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer

  2018cites this paper
• Second harmonic generation for collagen I characterization in rectal cancer patients with and without preoperative radiotherapy

  2017cites this paper
• Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples

  2017cites this paper
• Breast tumor stroma: A driving force in the development of resistance to therapies

  2017cites this paper
• Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: can we use enemy territory at our advantage?

  2017cites this paper
• Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture

  2016cites this paper
• SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells

  2016cites this paper
• Reduction of plasma fibulin-1 predicts poor survival in metastatic colorectal cancer

  2015cites this paper
• A top-down view of the tumor microenvironment: structure, cells and signaling

  2015cites this paper
• Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.

  2014cites this paper
• Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells

  2014cites this paper
• Biofunctionalization of Hydrogels for Engineering the Cellular Microenvironment

  2014cites this paper
• Miniaturized pre-clinical cancer models as research and diagnostic tools.

  2014cites this paper
• Original Paper Lip Squamous Carcinoma - Epidemiologic, Clinical, Evolutive and Therapeutical Aspects

  2013cites this paper
• Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast

  2013cites this paper
• Unraveling the molecular structure of the catalytic domain of matrix metalloproteinase-2 in complex with a triple-helical peptide by means of molecular dynamics simulations.

  2013cites this paper
• Concepts, Challenges and Perspectives in Cancer Research

  2012cites this paper
• Myc, Aurora Kinase A, and mutant p53R172H co-operate in a mouse model of metastatic skin carcinoma

  2012cites this paper
• Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses

  2012cites this paper
• Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview.

  2012cites this paper
• 1 Concepts , Challenges and Perspectives in Cancer Research

  2012cites this paper
• Genotoxic exposure: novel cause of selection for a functional ΔN-p53 isoform

  2011cites this paper
• Experimental Procedures to Assay Invasion-Associated Activities of Primary Cultured Fibroblasts

  2011cites this paper
• Engineered 3D models to study the cancer microenvironment as a determinant of drug response

  2011cites this paper
• Priming and potentiation of DNA damage response by fibronectin in human colon cancer cells and tumor-derived myofibroblasts.

  2011cites this paper
• The tumor ecosystem regulates the roads for invasion and metastasis.

  2011cites this paper
• Preneoplastic changes persist after IGF-IR downregulation and tumor regression

  2010cites this paper
• La matriz extracelular: de la mecánica molecular al microambiente tumoral (parte II)

  2010cites this paper
• The extracellular matrix in health and disease.

  2009cites this paper
• This information is current as Structures Podosome-LikeInvolvement of Proteases and Human Macrophages : Differential Three-Dimensional Migration Modes of Matrix Architecture Dictates

  2009cites this paper
• Adhesion-mediated apoptosis resistance in cancer.

  2009cites this paper
• Introduction to the Tumour Microenvironment Review Series

  2009cites this paper
• Matrix Architecture Dictates Three-Dimensional Migration Modes of Human Macrophages: Differential Involvement of Proteases and Podosome-Like Structures

  2009cites this paper
• Cancer Patient-Derived Scaffolds as In Vitro Preclinical Models for Immunotherapy Screening.

  year unknowncites this paper